Cold And Flu
NDC Package 55910-862-20
Package Information
Cold And Flu is do not take more than directed - see Overdose warningdo not exceed 12 softgels in any 24 hour periodadults and children 12 years of age and over: take 2 softgels every 4 hourschildren under 12 years of age: do not use. Marketed by Dolgencorp, Inc., this product is identified by NDC 55910-862 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1656815 - acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Capsule
- RxCUI: 1656815 - acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Capsule
- RxCUI: 1656815 - APAP 325 MG / Dextromethorphan Hydrobromide 10 MG / Guaifenesin 200 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 55910 - Dolgencorp, Inc.
- 55910-862 - Cold And Flu
- 55910-862-20 - 2 BLISTER PACK in 1 CARTON / 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK
- 55910-862 - Cold And Flu
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55910-862-20 identifies a specific commercial package of 2 blister pack in 1 carton / 10 capsule, liquid filled in 1 blister pack of Cold And Flu, labeled by Dolgencorp, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Dolgencorp, Inc. on March 12, 2020. The current certification is valid through December 31, 2025.
How is this Dolgencorp, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55910086220. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.